Please use this identifier to cite or link to this item: http://www.repositorio.ufop.br/jspui/handle/123456789/4709
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGiusti, Marcelo Franchini-
dc.contributor.authorSato, Monica Akemi-
dc.contributor.authorCardoso, Leonardo Máximo-
dc.contributor.authorBraga, Valdir de Andrade-
dc.contributor.authorColombari, Eduardo-
dc.date.accessioned2015-03-20T18:55:21Z-
dc.date.available2015-03-20T18:55:21Z-
dc.date.issued2011-
dc.identifier.citationGIUSTI, M. F. et al. Central antioxidant therapy inhibits parasympathetic baroreflex control in conscious rats. Neuroscience Letters, v. 489, p. 115-118, 2011. Disponível em: <http://www.sciencedirect.com/science/article/pii/S0304394010015314>. Acesso em: 08 nov. 2014.pt_BR
dc.identifier.issn0304-3940-
dc.identifier.urihttp://www.repositorio.ufop.br/handle/123456789/4709-
dc.description.abstractBaroreceptor reflex is an important system for neural control of blood pressure. Recently, reactive oxygen species (ROS) have been shown to play an important role in neuronal activity of central areas related to blood pressure control. The aim of this study was to investigate the effects elicited by ascorbic acid (AAC) and N-acetylcysteine (NAC) injections into the 4thV on the parasympathetic component of the baroreflex. Male Wistar rats were implanted with a stainless steel guide cannula into the 4thV. One day prior to the experiments, the femoral artery and vein were cannulated for pulsatile arterial pressure, mean arterial pressure and heart rate measurements and drug administration, respectively. After baseline recordings, the baroreflex was tested with a pressor dose of phenylephrine (PHE, 3_g/kg, i.v.) and a depressor dose of sodium nitroprusside (SNP, 30_g/kg, i.v.) before (control) and 5, 15, 30 and 60 min after AACorNACinto the 4thV. ControlPHEinjection induced baroreflex-mediated bradycardia (−93±13 bpm, n = 7). Interestingly, after AAC injection into the 4thV, PHE injection produced a transient tachycardia at 5 (40±23 bpm), 15 (26±22 bpm) and 30 min (59±21 bpm). No changes were observed in baroreflexmediated tachycardia evoked by SNP after AAC injection on 4thV (control: 151±23bpm vs. 135±18bpm at 5 min after AAC, n = 7). In the NAC treated group, PHE induced a reduction in reflex bradycardia at 5 min when compared to control (−11±17bpm vs. −83±15 bpm, n = 7). No changes were observed in baroreflex-mediated tachycardia evoked by SNP after NAC injection on 4thV. The antioxidants AAC and NAC may act in the central nervous system affecting the parasympathetic component of the cardiac baroreflex.pt_BR
dc.language.isoen_USpt_BR
dc.subjectBaroreceptor reflexpt_BR
dc.subjectAscorbic acidpt_BR
dc.subjectReactive oxygen speciespt_BR
dc.subjectBrainstempt_BR
dc.titleCentral antioxidant therapy inhibits parasympathetic baroreflex control in conscious rats.pt_BR
dc.typeArtigo publicado em periodicopt_BR
dc.rights.licenseO periódico Neuroscience Letters concede permissão para depósito deste artigo no Repositório Institucional da UFOP. Número da licença: 3525480396229.pt_BR
dc.identifier.doihttps://doi.org/10.1016/j.neulet.2010.11.077-
Appears in Collections:DECBI - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
ARTIGO_CentralAntioxidantTherapy.pdf318,74 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.